Skip to content
Belgium
-
Novadip Biosciences secures US$12M to advance regenerative therapy
Novadip will use the proceeds to advance NVD003, its lead autologous cell-based therapy, through late-stage clinical development and regulatory preparation.
-
Nyxoah enrolls first patient in US BREATHE study evaluating Genio OSA system
Nyxoah plans to enrol and implant up to 229 patients at as many as 25 sites, with participants receiving follow-up for up to five years after implantation.
-
Besins Healthcare expands drug delivery capabilities with UniD Manufacturing acquisition in Belgium
As part of the transaction, Besins Healthcare will take ownership of UniD Manufacturing’s production facility in Seraing, Belgium.